Novel Identification of CD74 as a Biomarker for Diagnosing and Prognosing Sepsis Patients
This study presents the first quantitative assessment of human plasma CD74 in sepsis patients. CD74 levels were significantly lower in the sepsis cohort. CD74 warrants further exploration as a potential prognostic and therapeutic target for sepsis.
Authors
- Fuzhou Hua (ORCID: https://orcid.org/0000-0002-6718-6490)
- Yuan Shu (ORCID: https://orcid.org/0000-0003-3145-7727)
- Ao Shi (ORCID: https://orcid.org/0000-0002-2970-4832)
- Jitao Ling (ORCID: https://orcid.org/0000-0002-1720-8620)
- Kaibo Hu (ORCID: https://orcid.org/0000-0002-0060-6729)
- Yixuan Chen (ORCID: https://orcid.org/0009-0005-5915-3743)
- Jing Zhang (ORCID: https://orcid.org/0000-0002-9231-0844)
- Peng Yu (ORCID: https://orcid.org/0009-0009-7553-6380)
- Shivon Mirza Sudesh
- Shuchun Yu
Institutions
- Nanchang University (CN)
- St George's, University of London (GB)
- Faculty (United Kingdom) (GB)
- Second Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/jir.s509089
- Citations
- 2
- Primary Topic
- Macrophage Migration Inhibitory Factor
- Type
- article
- Field-Weighted Citation Impact
- 1.59
Funders
- National Natural Science Foundation of China